684 related articles for article (PubMed ID: 17961741)
1. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
2. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
[TBL] [Abstract][Full Text] [Related]
3. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
5. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.
Dehdashti AR; Ganna A; Karabatsou K; Gentili F
Neurosurgery; 2008 May; 62(5):1006-15; discussion 1015-7. PubMed ID: 18580798
[TBL] [Abstract][Full Text] [Related]
6. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
7. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B
Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
9. [Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
Biermasz NR; Dekkers OM; Voormolen J; de Keizer RJ; Neelis KJ; Wiggers-de Bruïne FT; Smit JW; Arias AM; Romijn JA
Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2565-70. PubMed ID: 19174939
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas.
Pollock BE; Brown PD; Nippoldt TB; Young WF
Neurosurgery; 2008 Jun; 62(6):1271-6; discussion 1276-8. PubMed ID: 18824993
[TBL] [Abstract][Full Text] [Related]
13. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR; Gentili F
Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
15. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
16. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery.
Kabil MS; Eby JB; Shahinian HK
Minim Invasive Neurosurg; 2005 Dec; 48(6):348-54. PubMed ID: 16432784
[TBL] [Abstract][Full Text] [Related]
17. Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm.
Ku CR; Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 Dec; 71(2 Suppl Operative):ons192-203; discussion ons203. PubMed ID: 22743357
[TBL] [Abstract][Full Text] [Related]
18. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
19. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
